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Abstract
Recent studies have shown that virally encoded mRNA sequences of genome maintenance proteins from herpesviruses
contain clusters of unusual structural elements, G-quadruplexes, which modulate viral protein synthesis. Destabilization of
these G-quadruplexes can override the inhibitory effect on self-synthesis of these proteins. Here we show that the purine-
rich repetitive mRNA sequence of Epstein-Barr virus encoded nuclear antigen 1 (EBNA1) comprising G-quadruplex
structures, limits both the presentation of MHC class I-restricted CD8+ T cell epitopes by CD11c+ dendritic cells in draining
lymph nodes and early priming of antigen-specific CD8+ T-cells. Destabilization of the G-quadruplex structures through
codon-modification significantly enhanced in vivo antigen presentation and activation of virus-specific T cells. Ex vivo
imaging of draining lymph nodes by confocal microscopy revealed enhanced antigen-specific T-cell trafficking and APC-
CD8+ T-cell interactions in mice primed with viral vectors encoding a codon-modified EBNA1 protein. More importantly,
these antigen-specific T cells displayed enhanced expression of the T-box transcription factor and superior polyfunctionality
consistent with the qualitative impact of translation efficiency. These results provide an important insight into how viruses
exploit mRNA structure to down regulate synthesis of their viral maintenance proteins and delay priming of antigen-specific
T cells, thereby establishing a successful latent infection in vivo. Furthermore, targeting EBNA1 mRNA rather than protein by
small molecules or antisense oligonucleotides will enhance EBNA1 synthesis and the early priming of effector T cells, to
establish a more rapid immune response and prevent persistent infection.
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Introduction
The interaction of a peptide-MHC class I (pMHC-I) complex
on antigen presenting cells (APCs) with a T cell receptor (TCR) on
CD8+ T cells, initiates the activation of antigen-specific CD8+ T
cells [1]. Recent in vitro studies from many groups have revealed
that endogenously processed MHC class I-restricted epitopes are
predominantly generated from rapidly degraded defective ribo-
somal products (DRiPs) rather than from the degradation of full-
length, stable viral proteins [2,3,4,5,6]. This process suggests that
by regulating the production of antigen or DRiPs in host cells
during viral infection we could beneficially influence the gener-
ation and presentation of MHC class I-restricted epitopes and the
induction of antigen-specific immune responses. Indeed, earlier
studies by Ryan and colleagues have shown that the magnitude of
CD8+ T cell activation during mycobacterial infection is
determined by the level of antigen first encountered by naı¨ve T
cells [7]. Furthermore, modulation of antigen expression by slowly
replicating pathogens may facilitate their persistence by delaying
the development of acquired immune responses [8,9].
Epstein-Barr virus (EBV) is a classic example of a persistent
infection in which down-regulation of viral protein synthesis limits
antigen presentation to CD8+ T cells through the MHC class I
pathway. EBV encoded nuclear antigen 1 (EBNA1) is a critical
viral genome maintenance protein expressed in all EBV-associated
malignancies. Constraints on EBNA1 self-synthesis limit the
presentation of T cell epitopes on the surface of virus-infected
cells [10,11]. Extensive studies have shown that this restricted
presentation is due in part to an internal glycine-alanine repeat
(GAr) domain within EBNA1 [12,13,14]. Although it has been
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reported that the GAr encoded domain impedes translation of the
EBNA1 mRNA [6,15,16,17,18,19,20], the mechanism causing
this has remained unclear. There are reports that the EBNA1 GAr
polypeptide sequence delays the initiation of EBNA1 mRNA
translation [15,21]. However, other studies have clearly demon-
strated that the purine-rich, GAr mRNA structure limits EBNA1
synthesis, resulting in decreased presentation of EBNA1 to specific
CD8+ T cells [19,22]. Indeed, recent studies from our group have
revealed that the GAr mRNA includes cis-regulatory, G-quad-
ruplex structures that inhibit EBNA1 synthesis and thereby
modulate the endogenous presentation of EBNA1-specific CD8+
T cell epitopes [23].
Considering the importance of CD8+ T cells in controlling
primary and latent EBV infection, we hypothesized that the
translational efficiency of the EBNA1 mRNA may also influence
the priming of antigen-specific T cells in vivo. To test this
hypothesis we used two sequences of the EBNA1 gene encoding
identical proteins but with differential rates of translation of their
respective mRNAs to assess the impact of translational efficiency
on the induction of effector and memory CD8+ T cell responses. A
native EBNA1 GAr mRNA inhibits translation due to the
presence of G-quadruplex structures, whilst a codon-modified
EBNA1 GAr mRNA enhances translation due to destabilization of
the G-quadruplex structures [23]. These studies demonstrated that
the translational efficiency of the EBNA1 mRNAs directly
correlated with the MHC class I antigen presentation in vivo
and early priming of antigen-specific effector CD8+ T cells, while
the generation of a memory T cell response was not impacted.
Furthermore, the translational efficiency of EBNA1 mRNAs also
impacted on the functional profile of antigen-specific effector
CD8+ T cells, suggesting that changes in their activation are likely
related to the amount of antigen available.
Results
Ex vivo antigen presentation by CD11c+ DCs is influenced
by mRNA translational efficiency
To determine the impact of EBNA1 mRNA translational
efficiency on MHC class I-restricted antigen presentation in vivo,
we constructed both EBNA1-pcDNA3 (Fig. 1A–B) and adenoviral
EBNA1-GFP expression vectors (Fig. 1C–D) to generate mRNAs
with differential translational efficiency but encoding identical
proteins. These EBNA1 vectors were designed to express either
400 nucleotides of a native GAr mRNA (E1-GArN and Ad-E1-
GArN) or 400 nucleotides of a codon-modified GAr mRNA
(E1-GArM and Ad-E1-GArM). In addition, we also generated two
additional adenoviral EBNA1-GFP expression vectors encoding
full-length EBNA1 (Ad-E1-GFP; Fig. 1E) or EBNA1 with a
deleted GAr domain (Ad-E1-DGAr-GFP; Fig. 1F). The above
EBNA1 adenoviral expression vectors all demonstrated similar
adenovirus transduction efficiencies (Table S1). To assess the
endogenous loading of MHC class I molecules, the adenoviral
EBNA1-GFP expression constructs also encoded a model
H-2kb- restricted CD8+ T cell epitope SIINFEKL, comprising
OVA257–264 from the ovalbumin protein. Recent studies by our
group have demonstrated that the native purine-rich EBNA1 GAr
mRNA contains G-quadruplexes and these structures have been
shown to inhibit EBNA1 self-synthesis [23]. Following codon-
modification to reduce this purine-bias we demonstrated that
destabilization of the RNA G-quadruplex structures resulted in
enhanced EBNA1 synthesis [19,22] (Fig. 1G). Initially, we
challenged C57BL/6 mice with Ad-E1-GArN-GFP or Ad-E1-
GArM-GFP. Two days post-infection, CD11c+ DCs were
enriched from draining inguinal lymph nodes and incubated with
B3Z T cells, a CD8+ T cell hybridoma cell line that expresses lacZ
upon activation of its SIINFEKL-specific T cell receptor (Fig. 2A).
CD11c+ DCs isolated from mice infected with Ad-E1-GArM-
GFP, the more efficiently translated EBNA1 mRNA, demonstrat-
ed a significantly higher level of ex vivo presentation of the
H-2Kb-restricted SIINFEKL epitope (Fig. 2,B–C), which re-
mained consistent at different effector to target ratios (Fig. 2C).
These observations indicated that the translation efficiency of viral
mRNAs could influence the in vivo presentation of CD8+ T cell
epitopes by professional antigen presenting cells.
The translational efficiency of homologous viral mRNAs
in vivo influence DC-T cell interactions and antigen-
specific T cell recruitment
To further delineate the potential impact of viral mRNA
translational efficiency on the modulation of CD8+ T cell
immunity in vivo, we used confocal imaging of draining lymph
nodes to visualize the interaction of antigen presenting cells with
SIINFEKL-specific CD8+ T cells and the recruitment of these
effector cells. CFSE-labeled CD8+ OT-1 T cells were adoptively
transferred into C57BL/6 mice two hours prior to infection with
adenoviral expression vectors Ad-E1-GArN-GFP encoding native
EBNA1, or Ad-E1-GArM-GFP encoding codon-modified
EBNA1. Draining lymph nodes were harvested on day 2 for
frozen section and stained with anti-CD11c, anti-H-2Kb-SIIN
(25-D1.16) and DAPI. Mice infected with the vector encoding
native EBNA1, demonstrated a significantly reduced number of
CFSE+CD8+ OT-1 cells and H-2Kb-SIIN+ APCs in draining
lymph nodes when compared to mice infected with the vector
encoding codon-modified EBNA1 which generates a faster
translating EBNA1 mRNA due to destabilization of the native
G-quadruplex structures (Fig. 3A–D). Additionally, we observed
that mice infected with the vector expressing native EBNA1 also
demonstrated a significantly lower number of H-2Kb-SIIN+ APCs
within 3 mm distance of CFSE+CD8+ OT-1 cells compared to
mice challenged with the vector expressing the codon-modified
EBNA1, suggesting enhanced interactions between APC and
CD8+ T cells in mice immunized with a vector encoding a codon-
modified EBNA1 (Fig. 3E–G). These observations further empha-
size the critical role of translational efficiency of viral mRNAs in
Author Summary
Maintenance proteins of viruses establishing latent infec-
tions regulate their synthesis to levels sufficient for
maintaining persistent infection but below threshold levels
for host immune detection. The Epstein-Barr virus main-
tenance protein, EBNA1, has recently been shown to
contain unusual G-quadruplex structures within its repeat
mRNA that reduces its translational efficiency. In this study
we assess how modification of the EBNA1 mRNA repeat
sequence to destabilize the native G-quadruplex structures
and thereby increase translation, impacts on the activation
of EBNA1-specific T cells in vivo. Mice primed with viral
vectors encoding a more efficiently translated EBNA1
mRNA revealed increased trafficking of EBNA1-specific T
cells, an enhanced functional profile and increased
expression of transcription factors providing evidence for
a potential link between mRNA translational efficiency and
antigen presentation in vivo and the resultant impact on
the functional programming of effector T cells. These
findings suggest a novel approach to therapeutic devel-
opment through the use of antisense strategies or small
molecules targeting EBNA1 mRNA structure.
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Figure 1. Schematic description of EBNA1 expression constructs comprising different GAr mRNA sequences whilst encoding
identical protein sequences. Plasmids expressing EBNA1 were generated in either pcDNA3 for in vitro translation studies (A–B) or in Ad5-
adenoviral vectors (C–F) for immunological studies. (A–B) EBNA1 encoding 400 nucleotides of either native GAr (E1-GArN) or codon-modified GAr (E1-
GArM) respectively; (C–F) EBNA1 encoding 400 nucleotides of either native GAr (Ad-E1-GArN) or 400 nucleotides of codon-modified GAr (Ad-E1-
GArM); full-length EBNA1 (Ad-E1) or EBNA1 with a deleted GAr (Ad-E1-DGA) were fused in-frame to a C-terminal Green Fluorescent Protein (GFP) to
generate (Ad-E1-GArN-GFP); (Ad-E1-GArM-GFP); (Ad-E1-GFP) or (Ad-E1-DGA-GFP) respectively. The Ad-EBNA1-GFP expression constructs (C–F)
included insertion of a H2Kb-restricted ovalbumin CTL epitope, SIINFEKL, fused to the EBNA1 C-terminal sequence, allowing analysis of endogenous
processing of EBNA1 using a B3Z T-cell hybridoma in the immunological assays as outlined in the Materials and Methods. (G) In vitro translation assay
of pcDNA3 expression constructs encoding EBNA1 comprising either a native GAr (E1-GArN) or a codon-modified GAr (E1-GArM). Band intensities
from the IVT assays were quantified by densitometric analysis using ImageJ64 software. Mean 6 SD shown (n= 4).
doi:10.1371/journal.ppat.1004423.g001
Figure 2. Ex vivo antigen presentation by DCs is influenced by mRNA translation efficiency. (A) Flow chart illustrating the experimental
procedure. Female C57BL/6 mice were intramuscularly immunized with Ad-E1-GArN-GFP or Ad-E1-GArM-GFP. DLNs were pooled from 8 mice on day
2 following infection. Pan-DCs enriched from DLNs were incubated with B3Z cells at varying effector to target (E:T) ratios to assess antigen
presentation as described in the Materials and Methods. (B) Representative FACS plots showing b-galactosidase activity in B3Z hybridoma incubated
with DCs from mice immunized with Ad-E1-GArN-GFP or Ad-E1-GArM-GFP at an E:T ratio of 1:2. (C) Overall activation of B3Z cells at varying B3Z cells/
DCs ratios from mice immunized with Ad-E1-GArN-GFP or Ad-E1-GArM-GFP.
doi:10.1371/journal.ppat.1004423.g002
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not only modulating antigen presentation in vivo but also
influencing the number of effector T cells and in the interaction
of APCs and antigen-specific T cells in draining lymph nodes.
Differential translation of homologous EBNA1 mRNAs
impacts on CD8+ effector T cell proliferation,
transcriptional and polyfunctional profiles
Having established a direct impact of mRNA translational
efficiency on in vivo antigen presentation, APC-T cell interactions
and antigen-specific T cell numbers in draining lymph nodes, we
next assessed the impact of differential translation efficiency on
antigen-specific CD8+ T cell proliferation and activation. C57BL/
6 mice were adoptively transferred with CFSE-labelled CD8+ OT-
1 cells (56106 cells/mouse) and subsequently challenged with Ad-
E1-GArN-GFP or Ad-E1-GArM-GFP (16106 or 16108 pfu/
mouse). Mice were sacrificed on days 2 and 3 post-infection and
the proliferation, activation and functional properties of the
adoptively transferred OT-1 cells were evaluated from draining
inguinal lymph nodes. Proliferation of OT-1 cells was significantly
Figure 3. Antigen translation efficiency regulates Ag-specific T cell trafficking and DC-T cell interactions. Female C57BL/6 mice were
adoptively transferred with CFSE+CD8+ OT-1 cells, followed by intramuscular immunization with adenoviral expression vectors Ad-E1-GArN-GFP or
Ad-E1-GArM-GFP. DLNs were collected 2 days post-infection for frozen section. These were stained for nucleus, CD11c and Kb-SIINFEKL complex. (A)
Representative merged images (640) show the transferred CFSE+CD8+ OT-1 cells, CD11c-expressing cells and SIINFEKL epitope presenting cells. (B)
Representative merged images at high magnification (6100) show the transferred CFSE+CD8+ OT-1 cells, CD11c-expressing cells and SIINFEKL
epitope presenting cells. (C) Comparative analysis of the number of CFSE+CD8+ OT-1 cells in DLNs following infection with Ad-E1-GArN-GFP or Ad-E1-
GArM-GFP. (D) Comparative analysis of the number of and SIINFEKL epitope presenting cells in DLNs following infection with Ad-E1-GArN-GFP or Ad-
E1-GArM-GFP. (E) Representative images show the interactions between CD11c cells and SIINFEKL epitope presenting cells; CFSE+CD8+ OT-1 cells and
SIINFEKL epitope presenting cells. (F) Comparative analysis of the interaction between CD11c cells with H-2Kb-SIIN+ cells. (G) Comparative analysis of
the interaction between of H-2Kb-SIIN+ CD11c cells with CD8+ OT1 effector cells. (*p,0.05, Mann-Whitney).
doi:10.1371/journal.ppat.1004423.g003
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lower in mice challenged with an adenoviral vector encoding
native EBNA1, Ad-E1-GArN-GFP, (Fig. 4A–C). Interestingly, the
kinetics of proliferation of these effector cells correlated with the
dose of viral infection. We confirmed these results by infection
with a full-length native EBNA1-GFP adenoviral expression
construct, Ad-E1-GFP, which also showed low T cell proliferation,
whilst infection with an adenoviral EBNA1-GFP expression vector
where the GAr was deleted, Ad-E1-DGA-GFP, resulted in
enhanced proliferation of antigen-specific CD8+ T cells (data not
shown).
As the (IL-2/IL-2R) pathway is crucial for T-cell activation,
proliferation and differentiation [24,25] we next assessed the
expression of IL-2 receptors on CD8+ T cells. Antigen-specific
CD8+ T cells from mice challenged with an adenoviral vector
encoding codon-modified EBNA1, Ad-E1-GArM-GFP, led to a
significantly higher proportion of these cells being CD25+
(IL-2Ra) and CD122+ (IL-2Rb) (Fig. 4D). In addition, as CD27
plays a pivotal role in the generation, maintenance and
differentiation of cytotoxic T lymphocytes [26,27], the expression
of CD27 was also assessed and we observed that the majority of
SIINFEKL-specific CD8+ T cells isolated from mice challenged
with an adenoviral vector encoding codon-modified EBNA1,
Ad-E1-GArM-GFP, were also CD27+ (Fig. 4D), suggesting that T
cells primed with this vector are less differentiated and are more
likely to respond to IL-2.
Consistent with the data presented above, we also observed a
significant difference in the activation profile of SIINFEKL-
specific CD8+ T cells. Mice infected with an adenoviral vector
encoding EBNA1 with a codon-modified GAr domain, Ad-E1-
GArM-GFP, demonstrated a significantly higher proportion of
activated antigen-specific CD8+ T cells (Fig. 5). These T cells
included CD44+CD62L2CD692 and CD44+CD62L2CD69+
populations. Interestingly, mice infected with an adenoviral vector
encoding EBNA1 with a native GAr domain, Ad-E1-GArN-GFP,
showed a significantly higher number of CD442CD62L+CD692
antigen specific T cells in the DLNs, further emphasizing the
impact of G-quadruplex structures on the activation of T cells in
vivo (Fig. 5). It should be noted that the kinetics of T cell
activation correlated with the dose of viral infection. Infection
with high doses of adenoviral vectors (16108 pfu/mouse) was
Figure 4. T cell proliferation and activation are influenced by differentially translated EBNA1 mRNAs. (A) Representative FACS plot
shows the proliferation of transferred CD8+ OT-1 cells in murine DLNs 3 days post-infection with Ad-E1-GArN-GFP or Ad-E1-GArM-GFP. The numbers
in each box represent the percentage of CFSE labeled CD8+ OT-1 cells in murine DLNs. Each box represents one round of cell division. FSC: forward
scatter. (B–C) Data represent the mean 6 S.E.M. of the percentage of OT-1 CD8+ T cells in each division on days 2 and 3 post-infection with Ad-E1-
GArN-GFP or Ad-E1-GArM-GFP at two different viral dosages (16106 pfu/mouse) or (16108 pfu/mouse). (D) Expression of CD25, CD122 and CD27 on
days 1, 2 and 3 by transferred CD8+ OT-1 cells following infection with Ad-E1-GArN-GFP or Ad-E1-GArM-GFP (16106 pfu/mouse). Each vertical bar
represents the mean 6 SD (n = 5).
doi:10.1371/journal.ppat.1004423.g004
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co-incident with early activation of antigen-specific T cells (day 2),
while the peak of activation in mice challenged with a lower dose
of virus (16106 pfu/mouse) was not observed until day 3 (Fig. 5).
Previous reports have demonstrated that the T-box transcrip-
tional factors, T-bet and Eomesodermin (Eomes), play crucial roles
in regulating T cell differentiation and function including
expression of cytokines and cytotoxicity [28,29,30,31]. Ex vivo
analysis of SIINFEKL-specific effector T cells demonstrated that
mice infected with Ad-E1-GArM-GFP showed significantly higher
levels of T-bet expression on days 2 and 3 post-infection compared
to mice infected with Ad-E1-GArN-GFP (Fig. 6A–B). In contrast,
the levels of Eomes in antigen-specific effector T cells were not
significantly different in mice infected with Ad-E1-GArM-GFP or
Ad-E1-GArN-GFP (Fig. 6A–B). To investigate further the poten-
tial impact of T-bet expression, we assessed the polyfunctional
potentiality of antigen-specific T cells. For these analyses, T cells
Figure 5. T cell activation is influenced by differentially translated EBNA1 mRNAs. Expression of the T cell activation markers CD44, CD62L
and CD69 in the DLNs of mice infected with Ad-E1-GArN-GFP or Ad-E1-GArM-GFP (16106 pfu/mouse or 16108 pfu/mouse) on days 1, 2 and 3. Each
vertical bar represents the mean 6 S.E.M. (n = 5).
doi:10.1371/journal.ppat.1004423.g005
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from draining lymph nodes were stimulated in vitro with
SIINFEKL peptide and assessed for expression of the anti-viral
cytokines IFNc and TNFa and the cytotoxicity degranulation
marker CD107. T cells from the Ad-E1-GArM-GFP-infected mice
displayed significantly higher polyfunctional potentiality (IFNc+,
TNFa+ and CD107a+ or IFNc+ and CD107a+) when compared
to Ad-E1-GArN-GFP-infected mice (Fig. 6C). Similarly, infection
with Ad-E1-DGA-GFP, where the GAr domain has been deleted
resulting in improved translation of the E1-DGA-GFP mRNA,
also showed significantly enhanced expression of activation
markers (Fig. 6D) and polyfunctional antigen-specific T cells
(Fig. 6E) compared to infection with Ad-E1-GFP, a construct
expressing full-length native EBNA1. Mice infected with a control
recombinant EBNA1-GFP expression vector not encoding SIIN-
FEKL showed no antigen-specific T cell responses when
stimulated in vitro with SIINFEKL peptide (Fig. S1).
To confirm that these results were not due to an artifact of
adoptive T cell transfer, we repeated these studies in C57BL/6
mice without cell transfer. Naı¨ve mice were challenged with
Ad-E1-GArN-GFP or Ad-E1-GArM-GFP and the expression of
early activation markers and polyfunctional potentiality of primary
SIINFEKL-specific effector T cells were assessed on day 7 using
an H-2Kb-SIIN pentamer. Similar to the results demonstrated in
the adoptive T cell transfer setting, we observed a significantly
higher proportion of T cells from naı¨ve C57BL/6 mice infected
with Ad-E1-GArM-GFP, which were of the activated phenotype
CD44+CD69+CD62L2 and which displayed polyfunctional
potentiality compared to the T cells from naı¨ve C57BL/6 mice
infected with Ad-E1-GArN-GFP (Fig. 7A–B).
We also investigated whether the impact of mRNA translational
efficiency on an early effector T cell response also extends to the
generation and establishment of a memory response. C57BL/6
Figure 6. Differential translation of EBNA1 mRNAs impacts on the expression of transcriptional factors and antigen specific
functions in Ag-specific T cells from DLNs. Female C57BL/6 mice were adoptively transferred with CFSE+CD8+ OT-1 cells, followed by
intramuscular immunization with Ad-E1-GArN-GFP or Ad-E1-GArM-GFP virus (106 pfu/mouse) 2 hours following transfer. Mice were sacrificed on days
1, 2 or 3 post-infection. Expression of T-bet and Eomes in transferred CD8+ OT-1 cells was evaluated. (A) Representative FACS plots show the
expression of T-bet and Eomes in CFSE+CD8+ OT-1 cells. (B) Overall results of the expression of T-bet and Eomes in CFSE+CD8+ OT-1 cells at different
time points post-infection with Ad-E1-GArN-GFP or Ad-E1-GArM-GFP. (C) DLN cells were prepared from mice on day 3 post-infection with Ad-E1-
GArN-GFP or Ad-E1-GArM-GFP and the expression of IFN-c, TNF-a and translocation of CD107a by transferred CD8+ OT-1 cells was evaluated using a
standard 6 hour ICS assay. (D–E) Female C57BL/6 mice were adoptively transferred with CFSE-labeled CD8+ OT-1 cells (16106 cells/mouse) and
immunized intramuscularly with Ad-E1-GFP or Ad-E1-DGA-GFP virus (16106 pfu/mouse) 2 hours following transfer with DLNs harvested on day 3
post-infection to assess the activation and functions of antigen-specific CD8+ T cells. (D) The expression of T cell activation markers CD44, CD62L and
CD69 on CFSE+CD8+ OT-1 cells (E) Expression of IFN-c, TNF-a and translocation of CD107a by transferred CD8+ OT-1 cells. Mean 6 SD shown (n= 5).
doi:10.1371/journal.ppat.1004423.g006
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mice were challenged with Ad-E1-GArN-GFP and Ad-E1-GArM-
GFP and SIINFEKL-specific CD8+ T cell responses were assessed
on days 14 and 28. Antigen-specific T cells from mice infected
with Ad-E1-GArN-GFP and Ad-E1-GArM-GFP demonstrated
similar levels of activation markers (Fig. 8). Furthermore, these T
cells also showed comparable levels of the T-box transcription
factors T-bet and Eomes and a similar capacity to express IFNc
following stimulation with SIINFEKL peptide. Taken together,
these data clearly demonstrate that the native EBNA1 GAr
mRNA comprising G-quadruplex structures limits the availability
of peptide/MHC complexes on the cell surface of antigen
presenting cells and selectively impacts on the functional quality
of an early antigen-specific T cell response in vivo.
Discussion
Although the innate immune response is crucial in controlling
early stages of viral infection, rapid priming of an effective
adaptive cellular immune system can determine the outcome of
primary viral infection [32,33]. In particular, recruitment of virus-
specific CD8+ T cells and their maturation as effector cells is
achieved through an interaction between T-cell receptors and
MHC class I-peptide complexes on professional antigen presenting
cells [34]. Following activation, these effector T cells scan the
surface of virus-infected cells to detect viral peptides bound to
MHC class I molecules and eliminate these cells either by direct
lysis or by secreting cytokines/chemokines [35]. To counter this
effector mechanism, viruses have evolved multiple strategies to
limit the endogenous processing and presentation of viral peptides
[36,37]. Indeed, human herpes viruses including EBV, which are
known to establish persistent infection, have developed specific
strategies to suppress the expression of immunodominant antigens
[38,39]. While limiting the supply of viral peptides by controlling
the synthesis of viral proteins can prevent T cell recognition, this
strategy can also impact on viral fitness and compromise the ability
of viruses to establish persistent infection [40]. EBV-encoded
EBNA1 is a good example of a viral protein, which has successfully
evolved unique strategies to overcome this dilemma. This protein
includes an internal glycine-alanine repeat domain that not only
limits self-synthesis but also blocks proteasomal degradation
[6,13]. While restricted expression of this protein limits the
availability of peptide epitopes, the blockade of degradation
provides sufficient protein for maintenance of the viral genome in
virus-infected B cells.
A number of studies published over the last decade have shown
that in spite of the inhibitory effect of the internal GAr domain,
CD8+ T cell responses directed towards EBNA1 can be readily
detected in EBV seropositive individuals [2,3,41]. This paradox
was resolved following extensive in vitro molecular analysis of the
endogenous processing of EBNA1 which showed that CD8+ T cell
epitopes from this protein were predominantly generated from
newly synthesized RDPs rather than from the long-lived pool of
stable EBNA1 in EBV-infected B cells [2,3,6,15,17,19,21,22,40].
These observations have subsequently been further extended to
demonstrate that the generation of RDPs is intrinsically linked to
the rate at which proteins are synthesized [17]. It has been
reported that EBNA1 with its native GAr domain generates RDPs
less efficiently compared to EBNA1DGA, which is more efficiently
synthesized [20]. As a consequence, CD8+ T cell epitopes
generated from EBNA1DGA were more efficiently processed
and cells expressing EBNA1DGA were lysed in vitro at higher
levels by EBV-specific CTLs compared to cells expressing a poorly
translated full-length EBNA1. Based on these observations, we
hypothesized that an EBNA1 GAr-mediated inhibitory effect on
mRNA translation and RDP generation may be one of the crucial
mechanisms by which EBV modulates the kinetics of antigen
presentation and the priming of virus-specific CD8+ T cell
responses in vivo. Indeed, it has been recently revealed that the
EBNA1 GAr mRNA exploits G-quadruplex structure to inhibit
translation elongation by impeding ribosome transit, thereby
down-regulating EBNA1 synthesis and limiting the availability of
peptide epitopes.
The identification of inhibitory G-quadruplex structures within
EBNA1 has helped elucidate an important EBNA1 translational
regulatory mechanism. Earlier studies had proposed that the GAr
peptide sequence may interfere with translation initiation to down-
regulate EBNA1 synthesis [15], however toe-printing experiments
performed by the Shastri group demonstrated that inhibition of
EBNA1 synthesis was most likely not due to interference of
translation initiation [20]. Results from recent EBNA1 polysome
profiling experiments demonstrated that G-quadruplex structural
elements within the EBNA1 GAr mRNA act as steric blocks to
cause a stalling/dissociation of ribosomes [23]. This result
confirmed previous findings that reducing the purine-bias within
the EBNA1 GAr mRNA through codon-modification, whilst
maintaining the encoded protein sequence results in increased
EBNA1 mRNA translation [22,23]. We have more recently
demonstrated that codon-modification of the repeat sequence
Figure 7. The differential translation of EBNA1 mRNAs impacts on the activation and functional programming of antigen-specific T
cells. Female C57BL/6 mice were immunized intramuscularly with Ad-E1-GArN-GFP or Ad-E1-GArM-GFP virus (A–B). Mice were sacrificed on day 7
post-infection and spleen cells harvested to evaluate the activation and functions of antigen-specific CD8+ T cells. (A) Expression of T cell activation
markers CD44, CD62L and CD69. (B) Expression of IFN-c, TNF-a and translocation of CD107a by Ag-specific CD8+ OT-1 cells. Mean6 SD shown (n= 5).
doi:10.1371/journal.ppat.1004423.g007
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leads to destabilization of the G-quadruplex structures within
the GAr, which in turn leads to increased EBNA1 mRNA
translation. In the present study, EBNA1 variants displaying
distinct translational efficiencies for their respective native or
codon-modified mRNAs have been used to assess the influence of
mRNA translational efficiency on both in vivo antigen presenta-
tion and priming of virus-specific CD8+ T cell responses.
Comparison of the ex vivo antigen presentation by CD11c+ DCs
from the DLNs of mice infected with adenoviral vectors encoding
E1-GArN-GFP or E1-GArM-GFP revealed that CD8+ T cell
epitopes from these proteins were differentially presented on the
cell surface and this presentation correlated with their translational
efficiency. These observations extend previously published data on
the impact of translational efficiency on T cell recognition of
EBNA1 expressing virus-infected cells in vitro. While EBNA1
mRNA in humans is primarily expressed in B cells in vivo,
previous studies have suggested that dendritic cells may play an
important role in the priming of naı¨ve T cells, which recognize
EBV latent antigens [42,43]. This dendritic cell-mediated priming
may be mediated through either direct infection of these cells with
EBV [44,45,46] or through cross-presentation [47].
Having established that mRNA translational efficiency is
intrinsically linked to in vivo antigen presentation by professional
APCs, we further demonstrated the impact of mRNA translational
efficiency on CD8+ T cell priming by ex vivo imaging of draining
lymph nodes which showed enhanced antigen-specific T cell-APC
interactions in mice infected with an adenoviral vector expressing
a rapidly translated EBNA1 mRNA (Ad-E1-GArM-GFP). More
importantly, these antigen-specific T cells displayed superior
polyfunctionality and increased expression of the T-box transcrip-
tion factor, T-bet. Earlier studies, primarily in animal models,
have demonstrated the critical role of T-box transcription factors
in regulating effector function and the establishment of CD8+ T
cell memory. Thus antigen-specific T cells with high T-bet
expression display long-term resilience and protection from CD8+
T cell exhaustion. Recent studies have demonstrated that the level
of T-bet expression in virus-specific CD8+ T cells is associated with
the efficiency of endogenous antigen presentation, clonal expan-
sion and the phenotypic and functional profiles of antigen-specific
T cells [48]. Data presented in this study further extend these
observations and provide evidence for a potential link between
mRNA translational efficiency and antigen presentation in vivo
and its impact on the functional programming of effector T cells.
We note that in spite of a dramatic impact of mRNA translational
efficiency on early priming of CD8+ T cells, we observed only a
minimal impact on the generation of memory CD8+ T cell
responses.
The above observations provide an important insight into how
persistent viruses like EBV exploit mRNA translational efficiency
to modulate antigen presentation in vivo. In such a setting, viruses
would restrict early priming of antigen-specific T cells, thereby
escaping immune surveillance and allowing the establishment of a
successful latent infection. Furthermore, the techniques utilized
here may provide a general method to improve the immunoge-
nicity of poorly immunogenic viral proteins which restrict T cell
priming by limiting the availability of epitopes on the surface of
virus-infected cells. Enhanced mRNA translation through codon-
modification can dramatically enhance the endogenous presenta-
tion of immunodominant epitopes by professional APCs and
induce a strong effector T cell response. We predict that these
effector cells will recognize virus-infected cells more efficiently
compared to naturally-induced anti-viral T cells. These findings
also suggest a novel and alternate platform for designing anti-viral
strategies that focus on targeting RNA structure rather than
Figure 8. Differentially translated EBNA1 mRNAs have a minimal effect on Antigen-specific memory responses. Female C57BL/6 mice
were immunized intramuscularly with Ad-E1-GArN-GFP or Ad-E1-GArM-GFP virus. Spleen cells were collected on day 14 (top panel) or day 28 (lower
panel) post-infection. (A) Expression of T cell activation markers of CD44, CD62L and CD69 on SIINFEKL-specific CD8+ T cells. (B) Expression of
transcriptional factors Eomes and T-bet in SIINFEKL-specific CD8+ T cells. (C) The expression of IFN-c by SIINFEKL-specific CD8+ T cells was evaluated
using a standard 6- hour ICS assay. Mean 6 SD shown (n= 5).
doi:10.1371/journal.ppat.1004423.g008
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protein within gammaherpesviral ORFs. Such strategies may
include antisense oligonucleotides to enhance viral protein
synthesis and the early priming of effector T cells, to establish a
more rapid immune response and prevent persistent infection.
Materials and Methods
Ethics statement
This study was performed under strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Health and Medical Research
Council (Australia). The Animal Ethics Committee of the QIMR
Berghofer Medical Research Institute approved the protocol
[Protocol approval number: P353 (A0610-612)]. All viral infec-
tions were performed under gaseous (isoflurane) anaesthesia and
every effort was made to minimize suffering.
Cell lines
HEK293 cells were cultured in Dulbecco modified Eagle
medium supplemented with 10% fetal bovine serum, 2 mM
Glutamax, and 100 IU/ml penicillin-streptomycin. The SIIN-
FEKL-specific CD8+ T-cell hybridoma (B3Z) was maintained in
RPMI 1640 supplemented with 2 mM L-glutamine (Gibco, Life
Technology), 1 mM sodium pyruvate (Gibco, Life Technology),
50 mM 2-mercaptoethanol (Gibco, Life Technology), 100 IU/ml
penicillin, and 100 mg/ml streptomycin plus 10% FCS (R-10).
Antibodies and pentamer
APC-anti-CD3e, PE-Cy7-anti-CD3e, FITC-anti-CD3e, PE-
anti-CD8a, PerCp-anti-CD8a, Alex700-anti-CD19, FITC-anti-
CD44, APC-anti-CD44, V450-anti-CD44, PE-anti-IFN-c,
PE-Cy7-anti-TNF-a were purchased from BD Biosciences (Aus-
tralia); PE-Cy7-anti-CD25, FITC-anti-CD27, APC-anti-CD27,
Alexa647-anti-CD107a, eFluo450-anti-CD122, PE-anti-T-bet and
Alexa700-anti-Eomes and purified anti-mouse MHC I-SIINFEKL
complex (clone 25D) were purchased from eBioscience (Jomar
Bioscience, Kensington, SA., Australia); PerCp-Cy5.5-anti-
CD62L, PE-Cy7-anti-CD69 and purified anti-CD11c were
purchased from BioLegend, (Australian Biosearch, Karrinyup,
WA., Australia); APC-H-2Kb-SIINFEKL pentamer was pur-
chased from ProImmune (Oxford, UK).
Mice
C57BL/6 mice were purchased from Animal Resource Centre
(Perth, WA, Australia). OT-1 mice were bred and maintained
under conventional conditions in the animal facility at the
Queensland Institute of Medical Research. The Queensland
Institute of Medical Research Animal Ethics Committee approved
and monitored all animal procedures.
Generation of recombinant adenovirus encoding EBV
EBNA1
Full-length EBV-encoded EBNA1 (E1), EBNA1 with a deleted
GA repeat (E1-DGAr), EBNA1 expressing 400 nucleotides of
native GAr (E1-GAr400N) referred to as E1-(GArN) and EBNA1
expressing 400 nucleotides of codon-modified GAr (E1-GAr400M)
referred to as E1-(GArM) had been previously subcloned in-frame
with a sequence coding for GFP (pEGFP-N1; Clontech) to
generate E1-GFP, E1-DGAr-GFP, E1-GArN-GFP and E1-
GArM-GFP, respectively [2,17]. To enable the analysis of
endogenous processing of these proteins, a sequence encoding a
previously defined H-2Kb–restricted epitope SIINFEKL (referred
to as SIIN) was inserted into the EBNA1-GFP expression
constructs between the 39 end of the EBNA1 sequence and the
start of the GFP sequence. Recombinant adenovirus encoding E1-
SIIN-GFP, E1-DGAr-SIIN-GFP, E1-GArN-SIIN-GFP and E1-
GArM-SIIN-GFP were generated by a highly efficient, ligation-
based protocol of Adeno-X System (Clontech) [2,49]. Briefly, E1-
GArN-SIIN-GFP was cloned into the pshuttle plasmid between
NheI and XbaI restriction enzyme sites and transformed with dam
negative cells (SCS110). E1-GArM-SIIN-GFP, E1-DGAr-SIIN-
GFP and E1-SIIN-GFP were all digested with BspE1 and XcmI
enzymes and cloned into E1-GArN-SIIN-GFP-pshuttle 2 (replac-
ing the 400 nucleotides of native GAr sequence with either the full-
length GAr, no GAr or 400 nucleotides of codon-modified GAr) to
generate Ad-E1-SIIN-GFP, Ad-E1-DGAr-SIIN-GFP, Ad-E1-
GArN-SIIN-GFP and E1-GArM-SIIN-GFP, respectively. Viral
titers were verified using an end-point dilution assay. The viral
infection efficiency of all constructs was assessed with varying
dilutions into HEK293 cells and by measuring GFP fluorescence
using flow cytometry.
In vitro translation assays
EBNA1-pcDNA3 constructs expressing 400 nucleotides of
either native or codon-modified GAr (E1-GArN; E1-GArM) were
transcribed and translated in vitro with T7 RNA polymerase using
a coupled transcription/translation reticulocyte lysate system
(Promega, Madison WI) supplemented with 10 mCi 35[S]-methi-
onine (Perkin-Elmer Pty Ltd., Boston, MA.). Lysates were
subjected to SDS-PAGE followed by autoradiography and band
intensities were quantified by densitometric analysis using Im-
ageJ64 software.
B3Z T-cell activation assay
B3Z is a T-cell hybridoma expressing a TCR that is specifically
activated by the Ovalbumin (257–264) peptide, (SIINFEKL), in
the context of H-2Kb. The cells express the beta-galactosidase
(lacZ) gene under the control of the nuclear factor of activated T-
cell (NF-AT) element of the interleukin 2 enhancer, thereby
allowing the activation of B3Z T-cells to be measured by b-
galactosidase activity in single cells [50]. SIINFEKL-expressing
EBNA1 transfectants were incubated with B3Z cells at varying
effector to target cell ratios for 18 h. B3Z cells were harvested,
stained with anti-mouse CD3 and anti-mouse CD8 antibodies,
followed by osmotic loading of FDG (fluorescein di-b-galactoside;
Invitrogen), as previously described [51]. Briefly, B3Z cells were
resuspended in 25 ml staining buffer (PBS containing 4% FBS and
10 mM HEPES, pH 7.2), incubated for 10 minutes at 37uC
followed by the addition of 25 ml pre-warmed FDG (2 mM in de-
ionized water). After a further incubation at 37uC for 1 minute,
450 ml ice-cold staining buffer containing 1 mg/ml 7-Aminoactino-
mycin D (7-AAD) was added to each sample to stop osmotic
loading. Cells were kept on ice until assessment by flow cytom-
etry on a FACSCanto (BD Biosciences). Live B3Z cells
(7-AAD2CD3+CD8+ cells) were gated to analyze their activation
by measuring intracellular b-galactosidase activity.
Detection of antigen presentation by DCs
SIINFEKL-specific B3Z hybridoma cells were used to detect
cells presenting SIINFEKL peptide as previously described
[50,52]. Briefly, C57BL/6 mice were immunized with either E1-
GArM-GFP or E1-GArN-GFP at 16108 pfu/mouse. DLNs were
collected 2 days post-infection and DCs enriched from DLNs of
immunized mice and incubated with B3Z cells at different ratios
overnight in R-10. The cells were then harvested, loaded with
FDG and analyzed for LacZ activity on a FACSCanto.
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Confocal microscopy
CD8+ T cells were enriched from the spleens of OT-1 mice
using a mouse CD8+ T cell isolation kit II (Miltenyl Biotec
Australia). The purified CD8+ OT-1 cells were labeled with
0.5 mM carboxyfluorescein succinimidyl ester, CFSE, (Sigma, Mo.
USA) and adoptively transferred intravenously into C57BL/6
mice (56106 cells/mouse). Two hours following adoptive transfer,
the mice were immunized intramuscularly with either Ad-E1-
GArN-SIIN-GFP or Ad-E1-GArM-SIIN-GFP at a dose of
16108 pfu/mouse (3 mice/group). Draining inguinal lymph nodes
were removed 48 hours later and snap frozen in an optimal
cutting temperature (OCT) buffer (ProSci Tech, Qld. Australia).
Frozen sections (7 mm) were fixed in 75% acetone 25% ethanol for
5 minutes, washed in PBS and blocked with Vector Biotin
Blocking kit for 2610 minutes, followed by 60 min block in
Biocare Medical Mouse Block plus donkey anti-mouse Fab
fragments. Sections were washed in PBS before a further block
in 10% normal donkey serum in PBS for 30 minutes. Slides were
stained with anti-CD11c and anti-H2Kb SIIN or isotype control
antibodies for 60 min at room temperature followed by biotiny-
lated goat anti-Armenian hamster for 30 min. MACH1 Mouse
Probe was applied for 15 minutes. Sections were stained with
Alexa donkey anti-rabbit 647, streptavidin-555 applied for
30 minutes and incubated with DAPI for 10 minutes before
mounting with Dako Fluorescent mounting media. Slides were
examined on a Zeiss 512 Meta confocal microsope with a625 oil
emersion objective lens, taking 2 mm Z-sections, or660 objective
with 2 mm Z-sections. Tiling was used for whole-section imaging.
Images for publication were cropped, minimally adjusted for
brightness and contrast, and a 363 median filter applied using
ImageJ and Photoshop. Raw images were analyzed using Imaris
7.6.4: determining baseline fluorescence parameters from con-
trols, identifying cell types by fluorescence and size, and using
spot-analysis to calculate XYZ intercellular distances. Parameters
were saved and applied to all images within an experiment to
maintain objective consistency. At least 3 fields of view per slide
of each mouse were used for data analysis. Experiments were
repeated at least twice. Data were exported into Excel and
Graphpad Prism for statistical analysis. One-way ANOVA was
applied to compare groups, which we considered statistically
significant if p,0.05.
Adoptive transfer of CD8+ OT-1 T cells
CD8+ OT-1 T cells were purified from the spleens of OT-1
mice using a mouse CD8a+ T cell isolation kit II (Miltenyi Biotec
Australia, Cat# 130-095-236) according to the manufacturer’s
instruction. The isolated CD8+ OT-1 T cells were then labeled
with 5 mM CFSE as previously described [53] and adoptively
transferred to female C57BL/6 mice by intravenous injection.
Recipient mice were immunized with recombinant adenovirus two
hours following adoptive transfer.
Intracellular cytokine staining
CD8+ OT-1 T cells were surface stained with APC-H-2Kb-
SIINFEKL pentamer for 20 minutes then with anti-CD8a, anti-
CD19 before fixation and permeabilization and intracellular
staining for IFN-c and TNF-a. CFSE+CD8+ OT-1 T cells were
first surface stained with anti-CD8a and anti-CD3e mAbs, fixed
and permeabilized using cytofix/cytoperm (BD Biosciences, San
Diego, CA) and then labeled with anti-IFN-c and anti-TNF-a
mAbs. Pluripotent CTL responses were evaluated by ICS as
previously described [54]. Briefly splenocytes or local draining
lymph node (DLN) cells were restimulated with SIINFEKL
peptide (0.1 mg/ml) for 6 hours at 37uC in complete DMEM
(high glucose, Invitrogen, Grand Island, NY, USA) medium
supplemented with 10% FCS, 1 mM sodium pyruvate (Gibco,
Life Technology), MEM non-essential amino acids (Gibco, Life
Technology), 50 mM 2-mercaptoethanol, 100 U/ml penicillin
and 100 U/ml streptomycin (D-10). Anti-CD107a antibody was
added to the culture at the beginning. Brefeldin A and monensin
(BD Biosciences, San Diego, CA) were added 1 hour later to
prevent cytokine release. Cells were harvested after 6 hours for
staining.
T cell activation marker and transcriptional factor
staining
To determine the activation status of T cells after adoptive
transfer, splenocytes and local DLN cells were stained with anti-
CD8a, anti-CD44, anti-CD62L, anti-CD69, anti-CD25, anti-
CD27 and anti-CD122. In other experiments splenocytes and
local DLN cells were stained with APC-H-2Kb-SIINFEKL
pentamer for 20 minutes, followed by staining with anti-CD8a,
anti-CD19, anti-CD44, anti-CD62L, anti-CD69, or anti-CD25,
anti-CD27 and anti-CD122. Transcriptional factor expression was
determined by intracellular immunofluorescent staining. Cells
were first surface stained, then fixed and incubated with anti-T-bet
and anti-Eomes antibodies in permeabilization buffer (eBioscience,
Cat# 00-5521) before analysis by flow cytometry.
Statistical analysis
For the statistical analysis of the IVT and antigen presentation
experiments, a two-tailed paired Student’s t test was used. A P-
value,0.05 was considered significant.
Supporting Information
Figure S1 C57BL/6 mice were adoptively transferred with
CFSE+CD8+ OT-1 cells, followed by intramuscular immunization
two hours following transfer with recombinant EBNA1-SIIN-GFP
adenoviral expression vector variants Ad-E1-GArN-SIIN-GFP,
Ad-E1-GArM-SIIN-GFP, Ad-E1-SIIN-GFP, Ad-E1-DGA-SIIN-
GFP or a control vector lacking SIINFEKL, Ad-E1-GFP. Mice
were sacrificed and draining lymph node (DLN) cells were
prepared on days 1, 2 or 3 post-infection. Upper panels
demonstrate the overall proliferation of transferred CD8+ OT-1
T cells on days 1, 2 and 3 from mice immunized with a high dose
(16108 pfu/mouse) of each EBNA1-GFP expression vector. Lower
panels demonstrate the expression of T cell activation markers
CD44, CD62L and CD69 on days 1, 2 and 3 post-infection with
each EBNA1-GFP expression vector at 16108 pfu/mouse.
(DOCX)
Table S1 Adenovirus transduction efficiencies for Ad-E1-GArN-
GFP, Ad-E1-GArM-GFP, Ad-E1-GFP, Ad-E1-DGA-GFP in
HEK293 cells at varying MOIs was estimated by measuring the
percentage of GFP+ve cells and the GFP mean fluorescence
intensity (MFI) by flow cytometry. Experiment 1 compares all four
Ad-EBNA1-GFP variants at MOIs of 40 and 4. Experiment 2
compares Ad-E1-GArN-GFP and Ad-E1-GArM-GFP at MOIs of
50, 25 and 12.5.
(DOCX)
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